View in EDS HTML Full Text PDF Full Text

Enhancing Clinical Trial Sites in Low- and Middle-Income Countries to Facilitate Product Development in Response to the COVID-19 Pandemic.

Saved in:
Bibliographic Details
Title: Enhancing Clinical Trial Sites in Low- and Middle-Income Countries to Facilitate Product Development in Response to the COVID-19 Pandemic.
Authors: Kang SSY; International Vaccine Institute, Seoul, Republic of Korea.; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom., Tadesse BT; International Vaccine Institute, Seoul, Republic of Korea.; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.; Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany., Jeon HJ; International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Fallah MP; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia., Dereje N; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia., Ilesanmi OS; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia., Abay SM; International Vaccine Institute, Seoul, Republic of Korea.; Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia., Tekle BI; International Vaccine Institute, Seoul, Republic of Korea., Son HG; International Vaccine Institute, Seoul, Republic of Korea., Shrestha L; Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal., Shrestha A; Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal., Ramiso HV; Tropical Disease Foundation, Makati City, Philippines., Canouet V; International Vaccine Institute, Seoul, Republic of Korea., Kim Y; International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom., Asante KP; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana., Anim J; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana., Kaali S; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana., Capeding MR; Tropical Disease Foundation, Makati City, Philippines.; Asian Hospital and Medical Center, Muntinlupa City, Metro Manila, Philippines., Jani IV; Instituto Nacional de Saùde, Maputo, Mozambique., Capitine I; Instituto Nacional de Saùde, Maputo, Mozambique., Mahumane A; Instituto Nacional de Saùde, Maputo, Mozambique., Wartel TA; International Vaccine Institute, Seoul, Republic of Korea., Haselbeck AH; International Vaccine Institute, Seoul, Republic of Korea., Saluja T; International Vaccine Institute, Seoul, Republic of Korea., Marks F; International Vaccine Institute, Seoul, Republic of Korea.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.; The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, China.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Jul 22; Vol. 80 (12 Suppl 2), pp. S1-S8.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40694516
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Enhancing Clinical Trial Sites in Low- and Middle-Income Countries to Facilitate Product Development in Response to the COVID-19 Pandemic.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kang+SSY%22">Kang SSY</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tadesse+BT%22">Tadesse BT</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.; Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jeon+HJ%22">Jeon HJ</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Fallah+MP%22">Fallah MP</searchLink>; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia.<br /><searchLink fieldCode="AU" term="%22Dereje+N%22">Dereje N</searchLink>; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia.<br /><searchLink fieldCode="AU" term="%22Ilesanmi+OS%22">Ilesanmi OS</searchLink>; Africa Centres for Disease Control and Prevention, Science and Innovation Directorate, Addis Ababa, Ethiopia.<br /><searchLink fieldCode="AU" term="%22Abay+SM%22">Abay SM</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia.<br /><searchLink fieldCode="AU" term="%22Tekle+BI%22">Tekle BI</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Son+HG%22">Son HG</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shrestha+L%22">Shrestha L</searchLink>; Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.<br /><searchLink fieldCode="AU" term="%22Shrestha+A%22">Shrestha A</searchLink>; Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.<br /><searchLink fieldCode="AU" term="%22Ramiso+HV%22">Ramiso HV</searchLink>; Tropical Disease Foundation, Makati City, Philippines.<br /><searchLink fieldCode="AU" term="%22Canouet+V%22">Canouet V</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Asante+KP%22">Asante KP</searchLink>; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana.<br /><searchLink fieldCode="AU" term="%22Anim+J%22">Anim J</searchLink>; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana.<br /><searchLink fieldCode="AU" term="%22Kaali+S%22">Kaali S</searchLink>; Kintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo, Ghana.<br /><searchLink fieldCode="AU" term="%22Capeding+MR%22">Capeding MR</searchLink>; Tropical Disease Foundation, Makati City, Philippines.; Asian Hospital and Medical Center, Muntinlupa City, Metro Manila, Philippines.<br /><searchLink fieldCode="AU" term="%22Jani+IV%22">Jani IV</searchLink>; Instituto Nacional de Saùde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Capitine+I%22">Capitine I</searchLink>; Instituto Nacional de Saùde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Mahumane+A%22">Mahumane A</searchLink>; Instituto Nacional de Saùde, Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Wartel+TA%22">Wartel TA</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Haselbeck+AH%22">Haselbeck AH</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Saluja+T%22">Saluja T</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Marks+F%22">Marks F</searchLink>; International Vaccine Institute, Seoul, Republic of Korea.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.; The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2025 Jul 22; Vol. 80 (12 Suppl 2), pp. S1-S8.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40694516
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciaf094
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: S1
    Titles:
      – TitleFull: Enhancing Clinical Trial Sites in Low- and Middle-Income Countries to Facilitate Product Development in Response to the COVID-19 Pandemic.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kang SSY
      – PersonEntity:
          Name:
            NameFull: Tadesse BT
      – PersonEntity:
          Name:
            NameFull: Jeon HJ
      – PersonEntity:
          Name:
            NameFull: Fallah MP
      – PersonEntity:
          Name:
            NameFull: Dereje N
      – PersonEntity:
          Name:
            NameFull: Ilesanmi OS
      – PersonEntity:
          Name:
            NameFull: Abay SM
      – PersonEntity:
          Name:
            NameFull: Tekle BI
      – PersonEntity:
          Name:
            NameFull: Son HG
      – PersonEntity:
          Name:
            NameFull: Shrestha L
      – PersonEntity:
          Name:
            NameFull: Shrestha A
      – PersonEntity:
          Name:
            NameFull: Ramiso HV
      – PersonEntity:
          Name:
            NameFull: Canouet V
      – PersonEntity:
          Name:
            NameFull: Kim Y
      – PersonEntity:
          Name:
            NameFull: Asante KP
      – PersonEntity:
          Name:
            NameFull: Anim J
      – PersonEntity:
          Name:
            NameFull: Kaali S
      – PersonEntity:
          Name:
            NameFull: Capeding MR
      – PersonEntity:
          Name:
            NameFull: Jani IV
      – PersonEntity:
          Name:
            NameFull: Capitine I
      – PersonEntity:
          Name:
            NameFull: Mahumane A
      – PersonEntity:
          Name:
            NameFull: Wartel TA
      – PersonEntity:
          Name:
            NameFull: Haselbeck AH
      – PersonEntity:
          Name:
            NameFull: Saluja T
      – PersonEntity:
          Name:
            NameFull: Marks F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 07
              Text: 2025 Jul 22
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 12 Suppl 2
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1